Global Diabetic Retinopathy Treatment Market Insights, Forecast to 2031

Report ID: 1667221 | Published Date: Mar 2026 | No. of Page: 113 | Base Year: 2025 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetic Retinopathy Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Proliferative Diabetic Retinopathy (PDR)
        1.2.3 Non-Proliferative Diabetic Retinopathy (NPDR)
    1.3 Market by Application
        1.3.1 Global Diabetic Retinopathy Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Ophthalmic Clinics
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Hospitals
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Diabetic Retinopathy Treatment Market Perspective (2017-2028)
    2.2 Diabetic Retinopathy Treatment Growth Trends by Region
        2.2.1 Diabetic Retinopathy Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Diabetic Retinopathy Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Diabetic Retinopathy Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Diabetic Retinopathy Treatment Market Dynamics
        2.3.1 Diabetic Retinopathy Treatment Industry Trends
        2.3.2 Diabetic Retinopathy Treatment Market Drivers
        2.3.3 Diabetic Retinopathy Treatment Market Challenges
        2.3.4 Diabetic Retinopathy Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Diabetic Retinopathy Treatment Players by Revenue
        3.1.1 Global Top Diabetic Retinopathy Treatment Players by Revenue (2017-2022)
        3.1.2 Global Diabetic Retinopathy Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Diabetic Retinopathy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Diabetic Retinopathy Treatment Revenue
    3.4 Global Diabetic Retinopathy Treatment Market Concentration Ratio
        3.4.1 Global Diabetic Retinopathy Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Treatment Revenue in 2021
    3.5 Diabetic Retinopathy Treatment Key Players Head office and Area Served
    3.6 Key Players Diabetic Retinopathy Treatment Product Solution and Service
    3.7 Date of Enter into Diabetic Retinopathy Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Retinopathy Treatment Breakdown Data by Type
    4.1 Global Diabetic Retinopathy Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Diabetic Retinopathy Treatment Forecasted Market Size by Type (2023-2028)
5 Diabetic Retinopathy Treatment Breakdown Data by Application
    5.1 Global Diabetic Retinopathy Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Diabetic Retinopathy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Diabetic Retinopathy Treatment Market Size (2017-2028)
    6.2 North America Diabetic Retinopathy Treatment Market Size by Type
        6.2.1 North America Diabetic Retinopathy Treatment Market Size by Type (2017-2022)
        6.2.2 North America Diabetic Retinopathy Treatment Market Size by Type (2023-2028)
        6.2.3 North America Diabetic Retinopathy Treatment Market Share by Type (2017-2028)
    6.3 North America Diabetic Retinopathy Treatment Market Size by Application
        6.3.1 North America Diabetic Retinopathy Treatment Market Size by Application (2017-2022)
        6.3.2 North America Diabetic Retinopathy Treatment Market Size by Application (2023-2028)
        6.3.3 North America Diabetic Retinopathy Treatment Market Share by Application (2017-2028)
    6.4 North America Diabetic Retinopathy Treatment Market Size by Country
        6.4.1 North America Diabetic Retinopathy Treatment Market Size by Country (2017-2022)
        6.4.2 North America Diabetic Retinopathy Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Diabetic Retinopathy Treatment Market Size (2017-2028)
    7.2 Europe Diabetic Retinopathy Treatment Market Size by Type
        7.2.1 Europe Diabetic Retinopathy Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Diabetic Retinopathy Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Diabetic Retinopathy Treatment Market Share by Type (2017-2028)
    7.3 Europe Diabetic Retinopathy Treatment Market Size by Application
        7.3.1 Europe Diabetic Retinopathy Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Diabetic Retinopathy Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Diabetic Retinopathy Treatment Market Share by Application (2017-2028)
    7.4 Europe Diabetic Retinopathy Treatment Market Size by Country
        7.4.1 Europe Diabetic Retinopathy Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Diabetic Retinopathy Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Diabetic Retinopathy Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Type
        8.2.1 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Diabetic Retinopathy Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Application
        8.3.1 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Diabetic Retinopathy Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Region
        8.4.1 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Diabetic Retinopathy Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Diabetic Retinopathy Treatment Market Size (2017-2028)
    9.2 Latin America Diabetic Retinopathy Treatment Market Size by Type
        9.2.1 Latin America Diabetic Retinopathy Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Diabetic Retinopathy Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Diabetic Retinopathy Treatment Market Share by Type (2017-2028)
    9.3 Latin America Diabetic Retinopathy Treatment Market Size by Application
        9.3.1 Latin America Diabetic Retinopathy Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Diabetic Retinopathy Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Diabetic Retinopathy Treatment Market Share by Application (2017-2028)
    9.4 Latin America Diabetic Retinopathy Treatment Market Size by Country
        9.4.1 Latin America Diabetic Retinopathy Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Diabetic Retinopathy Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Diabetic Retinopathy Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Type
        10.2.1 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Diabetic Retinopathy Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Application
        10.3.1 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Diabetic Retinopathy Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Country
        10.4.1 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Diabetic Retinopathy Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Regeneron Pharmaceuticals
        11.1.1 Regeneron Pharmaceuticals Company Details
        11.1.2 Regeneron Pharmaceuticals Business Overview
        11.1.3 Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Introduction
        11.1.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.1.5 Regeneron Pharmaceuticals Recent Developments
    11.2 ThromboGenics
        11.2.1 ThromboGenics Company Details
        11.2.2 ThromboGenics Business Overview
        11.2.3 ThromboGenics Diabetic Retinopathy Treatment Introduction
        11.2.4 ThromboGenics Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.2.5 ThromboGenics Recent Developments
    11.3 Genentech
        11.3.1 Genentech Company Details
        11.3.2 Genentech Business Overview
        11.3.3 Genentech Diabetic Retinopathy Treatment Introduction
        11.3.4 Genentech Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.3.5 Genentech Recent Developments
    11.4 Bayer Healthcare
        11.4.1 Bayer Healthcare Company Details
        11.4.2 Bayer Healthcare Business Overview
        11.4.3 Bayer Healthcare Diabetic Retinopathy Treatment Introduction
        11.4.4 Bayer Healthcare Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.4.5 Bayer Healthcare Recent Developments
    11.5 Alimera Sciences
        11.5.1 Alimera Sciences Company Details
        11.5.2 Alimera Sciences Business Overview
        11.5.3 Alimera Sciences Diabetic Retinopathy Treatment Introduction
        11.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.5.5 Alimera Sciences Recent Developments
    11.6 Actavis
        11.6.1 Actavis Company Details
        11.6.2 Actavis Business Overview
        11.6.3 Actavis Diabetic Retinopathy Treatment Introduction
        11.6.4 Actavis Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.6.5 Actavis Recent Developments
    11.7 BCN Peptides
        11.7.1 BCN Peptides Company Details
        11.7.2 BCN Peptides Business Overview
        11.7.3 BCN Peptides Diabetic Retinopathy Treatment Introduction
        11.7.4 BCN Peptides Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.7.5 BCN Peptides Recent Developments
    11.8 Novartis
        11.8.1 Novartis Company Details
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Diabetic Retinopathy Treatment Introduction
        11.8.4 Novartis Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.8.5 Novartis Recent Developments
    11.9 Ampio Pharmaceuticals
        11.9.1 Ampio Pharmaceuticals Company Details
        11.9.2 Ampio Pharmaceuticals Business Overview
        11.9.3 Ampio Pharmaceuticals Diabetic Retinopathy Treatment Introduction
        11.9.4 Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.9.5 Ampio Pharmaceuticals Recent Developments
    11.10 Kowa Group
        11.10.1 Kowa Group Company Details
        11.10.2 Kowa Group Business Overview
        11.10.3 Kowa Group Diabetic Retinopathy Treatment Introduction
        11.10.4 Kowa Group Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.10.5 Kowa Group Recent Developments
    11.11 Sirnaomicsorporation
        11.11.1 Sirnaomicsorporation Company Details
        11.11.2 Sirnaomicsorporation Business Overview
        11.11.3 Sirnaomicsorporation Diabetic Retinopathy Treatment Introduction
        11.11.4 Sirnaomicsorporation Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.11.5 Sirnaomicsorporation Recent Developments
    11.12 Abbott Laboratories
        11.12.1 Abbott Laboratories Company Details
        11.12.2 Abbott Laboratories Business Overview
        11.12.3 Abbott Laboratories Diabetic Retinopathy Treatment Introduction
        11.12.4 Abbott Laboratories Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.12.5 Abbott Laboratories Recent Developments
    11.13 Glycadia Pharmaceuticals
        11.13.1 Glycadia Pharmaceuticals Company Details
        11.13.2 Glycadia Pharmaceuticals Business Overview
        11.13.3 Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Introduction
        11.13.4 Glycadia Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.13.5 Glycadia Pharmaceuticals Recent Developments
    11.14 Alcon Laboratories
        11.14.1 Alcon Laboratories Company Details
        11.14.2 Alcon Laboratories Business Overview
        11.14.3 Alcon Laboratories Diabetic Retinopathy Treatment Introduction
        11.14.4 Alcon Laboratories Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.14.5 Alcon Laboratories Recent Developments
    11.15 Parexel International
        11.15.1 Parexel International Company Details
        11.15.2 Parexel International Business Overview
        11.15.3 Parexel International Diabetic Retinopathy Treatment Introduction
        11.15.4 Parexel International Revenue in Diabetic Retinopathy Treatment Business (2017-2022)
        11.15.5 Parexel International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Diabetic Retinopathy Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Proliferative Diabetic Retinopathy (PDR)
    Table 3. Key Players of Non-Proliferative Diabetic Retinopathy (NPDR)
    Table 4. Global Diabetic Retinopathy Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Diabetic Retinopathy Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Diabetic Retinopathy Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Diabetic Retinopathy Treatment Market Share by Region (2017-2022)
    Table 8. Global Diabetic Retinopathy Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Diabetic Retinopathy Treatment Market Share by Region (2023-2028)
    Table 10. Diabetic Retinopathy Treatment Market Trends
    Table 11. Diabetic Retinopathy Treatment Market Drivers
    Table 12. Diabetic Retinopathy Treatment Market Challenges
    Table 13. Diabetic Retinopathy Treatment Market Restraints
    Table 14. Global Diabetic Retinopathy Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Diabetic Retinopathy Treatment Revenue Share by Players (2017-2022)
    Table 16. Global Top Diabetic Retinopathy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy Treatment as of 2021)
    Table 17. Ranking of Global Top Diabetic Retinopathy Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Diabetic Retinopathy Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Diabetic Retinopathy Treatment Product Solution and Service
    Table 21. Date of Enter into Diabetic Retinopathy Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Diabetic Retinopathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Diabetic Retinopathy Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Diabetic Retinopathy Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Diabetic Retinopathy Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Diabetic Retinopathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Diabetic Retinopathy Treatment Revenue Share by Application (2017-2022)
    Table 29. Global Diabetic Retinopathy Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Diabetic Retinopathy Treatment Revenue Share by Application (2023-2028)
    Table 31. North America Diabetic Retinopathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Diabetic Retinopathy Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Diabetic Retinopathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Diabetic Retinopathy Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Diabetic Retinopathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Diabetic Retinopathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Diabetic Retinopathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Diabetic Retinopathy Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Diabetic Retinopathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Diabetic Retinopathy Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Diabetic Retinopathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Diabetic Retinopathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Diabetic Retinopathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Diabetic Retinopathy Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Diabetic Retinopathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Diabetic Retinopathy Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Diabetic Retinopathy Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Diabetic Retinopathy Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Diabetic Retinopathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Diabetic Retinopathy Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Diabetic Retinopathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Diabetic Retinopathy Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Diabetic Retinopathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Diabetic Retinopathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Diabetic Retinopathy Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Diabetic Retinopathy Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Diabetic Retinopathy Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Diabetic Retinopathy Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Diabetic Retinopathy Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Diabetic Retinopathy Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Regeneron Pharmaceuticals Company Details
    Table 62. Regeneron Pharmaceuticals Business Overview
    Table 63. Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Product
    Table 64. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 65. Regeneron Pharmaceuticals Recent Developments
    Table 66. ThromboGenics Company Details
    Table 67. ThromboGenics Business Overview
    Table 68. ThromboGenics Diabetic Retinopathy Treatment Product
    Table 69. ThromboGenics Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 70. ThromboGenics Recent Developments
    Table 71. Genentech Company Details
    Table 72. Genentech Business Overview
    Table 73. Genentech Diabetic Retinopathy Treatment Product
    Table 74. Genentech Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 75. Genentech Recent Developments
    Table 76. Bayer Healthcare Company Details
    Table 77. Bayer Healthcare Business Overview
    Table 78. Bayer Healthcare Diabetic Retinopathy Treatment Product
    Table 79. Bayer Healthcare Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 80. Bayer Healthcare Recent Developments
    Table 81. Alimera Sciences Company Details
    Table 82. Alimera Sciences Business Overview
    Table 83. Alimera Sciences Diabetic Retinopathy Treatment Product
    Table 84. Alimera Sciences Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 85. Alimera Sciences Recent Developments
    Table 86. Actavis Company Details
    Table 87. Actavis Business Overview
    Table 88. Actavis Diabetic Retinopathy Treatment Product
    Table 89. Actavis Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 90. Actavis Recent Developments
    Table 91. BCN Peptides Company Details
    Table 92. BCN Peptides Business Overview
    Table 93. BCN Peptides Diabetic Retinopathy Treatment Product
    Table 94. BCN Peptides Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 95. BCN Peptides Recent Developments
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Diabetic Retinopathy Treatment Product
    Table 99. Novartis Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 100. Novartis Recent Developments
    Table 101. Ampio Pharmaceuticals Company Details
    Table 102. Ampio Pharmaceuticals Business Overview
    Table 103. Ampio Pharmaceuticals Diabetic Retinopathy Treatment Product
    Table 104. Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 105. Ampio Pharmaceuticals Recent Developments
    Table 106. Kowa Group Company Details
    Table 107. Kowa Group Business Overview
    Table 108. Kowa Group Diabetic Retinopathy Treatment Product
    Table 109. Kowa Group Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 110. Kowa Group Recent Developments
    Table 111. Sirnaomicsorporation Company Details
    Table 112. Sirnaomicsorporation Business Overview
    Table 113. Sirnaomicsorporation Diabetic Retinopathy Treatment Product
    Table 114. Sirnaomicsorporation Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 115. Sirnaomicsorporation Recent Developments
    Table 116. Abbott Laboratories Company Details
    Table 117. Abbott Laboratories Business Overview
    Table 118. Abbott Laboratories Diabetic Retinopathy Treatment Product
    Table 119. Abbott Laboratories Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 120. Abbott Laboratories Recent Developments
    Table 121. Glycadia Pharmaceuticals Company Details
    Table 122. Glycadia Pharmaceuticals Business Overview
    Table 123. Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Product
    Table 124. Glycadia Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 125. Glycadia Pharmaceuticals Recent Developments
    Table 126. Alcon Laboratories Company Details
    Table 127. Alcon Laboratories Business Overview
    Table 128. Alcon Laboratories Diabetic Retinopathy Treatment Product
    Table 129. Alcon Laboratories Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 130. Alcon Laboratories Recent Developments
    Table 131. Parexel International Company Details
    Table 132. Parexel International Business Overview
    Table 133. Parexel International Diabetic Retinopathy Treatment Product
    Table 134. Parexel International Revenue in Diabetic Retinopathy Treatment Business (2017-2022) & (US$ Million)
    Table 135. Parexel International Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetic Retinopathy Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Proliferative Diabetic Retinopathy (PDR) Features
    Figure 3. Non-Proliferative Diabetic Retinopathy (NPDR) Features
    Figure 4. Global Diabetic Retinopathy Treatment Market Share by Application: 2021 VS 2028
    Figure 5. Ophthalmic Clinics Case Studies
    Figure 6. Ambulatory Surgical Centers Case Studies
    Figure 7. Hospitals Case Studies
    Figure 8. Other Case Studies
    Figure 9. Diabetic Retinopathy Treatment Report Years Considered
    Figure 10. Global Diabetic Retinopathy Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Diabetic Retinopathy Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Diabetic Retinopathy Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Diabetic Retinopathy Treatment Market Share by Players in 2021
    Figure 14. Global Top Diabetic Retinopathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Treatment Revenue in 2021
    Figure 16. North America Diabetic Retinopathy Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Diabetic Retinopathy Treatment Market Size Market Share by Type (2017-2028)
    Figure 18. North America Diabetic Retinopathy Treatment Market Size Market Share by Application (2017-2028)
    Figure 19. North America Diabetic Retinopathy Treatment Market Size Share by Country (2017-2028)
    Figure 20. United States Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Diabetic Retinopathy Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Diabetic Retinopathy Treatment Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Diabetic Retinopathy Treatment Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Diabetic Retinopathy Treatment Market Size Share by Country (2017-2028)
    Figure 26. Germany Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Diabetic Retinopathy Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Diabetic Retinopathy Treatment Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Diabetic Retinopathy Treatment Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Diabetic Retinopathy Treatment Market Size Share by Region (2017-2028)
    Figure 36. China Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Diabetic Retinopathy Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Diabetic Retinopathy Treatment Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Diabetic Retinopathy Treatment Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Diabetic Retinopathy Treatment Market Size Share by Country (2017-2028)
    Figure 46. Mexico Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Diabetic Retinopathy Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Diabetic Retinopathy Treatment Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Diabetic Retinopathy Treatment Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Diabetic Retinopathy Treatment Market Size Share by Country (2017-2028)
    Figure 52. Turkey Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Diabetic Retinopathy Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 56. ThromboGenics Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 57. Genentech Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 58. Bayer Healthcare Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 59. Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 60. Actavis Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 61. BCN Peptides Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 63. Ampio Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 64. Kowa Group Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 65. Sirnaomicsorporation Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 66. Abbott Laboratories Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 67. Glycadia Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 68. Alcon Laboratories Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 69. Parexel International Revenue Growth Rate in Diabetic Retinopathy Treatment Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Regeneron Pharmaceuticals
ThromboGenics
Genentech
Bayer Healthcare
Alimera Sciences
Actavis
BCN Peptides
Novartis
Ampio Pharmaceuticals
Kowa Group
Sirnaomicsorporation
Abbott Laboratories
Glycadia Pharmaceuticals
Alcon Laboratories
Parexel International
Frequently Asked Questions
Diabetic Retinopathy Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetic Retinopathy Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetic Retinopathy Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Digital Scent

Digital Scent market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Digital Twins

Digital Twins market is segmented by players, region (country), by Type and by Application. Playe ... Read More